Document is current
Any future updates will be listed below
-
Authors
Zandl-Lang, Martina https://orcid.org/0000-0003-0522-4372
Züllig, Thomas
Holzer, Michael
Eichmann, Thomas O.
Darnhofer, Barbara
Schwerin-Nagel, Annette
Zobel, Joachim
Haidl, Harald
Biebl, Ariane
Köfeler, Harald
Plecko, Barbara
-
Funding
Funding for this research was provided by:
Austrian Science Fund (T-1343)
Medical University of Graz
- License Information
-
More Information
Article History
Received: 8 November 2024
Revised: 5 January 2025
Accepted: 7 January 2025
First Online: 4 February 2025
Declarations
:
: Financial interest: The authors declare no financial conflict of interest. Non-financial interest: BP and ASN has served on advisory boards for Biogen/Nusinersen and Novartis/Zolgensma. ASN has additionally served on advisory board for Roche/Risdiplam.
: All study procedures were approved by the Ethics Committee of the Medical University of Graz (approval number 31-162 ex 18/19) and by the Ethics Commission of the Johannes Kepler University Linz (approval number 1103/2019). Written informed consent was received prior to participation.
: Informed consent was obtained from all individual participants and their legal guardians included in the study.
